PepGen Ownership

PEPG Stock  USD 1.44  0.40  21.74%   
PepGen owns a total of 32.6 Million outstanding shares. The majority of PepGen outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in PepGen to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in PepGen. Please pay attention to any change in the institutional holdings of PepGen as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PepGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
For more detail on how to invest in PepGen Stock please use our How to Invest in PepGen guide.

PepGen Stock Ownership Analysis

About 96.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.34. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PepGen recorded a loss per share of 2.98. The entity had not issued any dividends in recent years. PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts. Pepgen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 36 people. To find out more about PepGen contact James McArthur at 781 797 0979 or learn more at https://pepgen.com.

PepGen Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific PepGen insiders, such as employees or executives, is commonly permitted as long as it does not rely on PepGen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases PepGen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Mellion Michelle L over three months ago
Disposition of 500 shares by Mellion Michelle L of PepGen at 10.21 subject to Rule 16b-3
 
Mellion Michelle L over three months ago
Disposition of 1086 shares by Mellion Michelle L of PepGen at 10.21 subject to Rule 16b-3
 
Mellion Michelle L over six months ago
Disposition of 7571 shares by Mellion Michelle L of PepGen at 18.0612 subject to Rule 16b-3
 
Mellion Michelle L over six months ago
Disposition of 201 shares by Mellion Michelle L of PepGen at 18.0051 subject to Rule 16b-3
 
Mellion Michelle L over six months ago
Disposition of 12625 shares by Mellion Michelle L of PepGen at 18.2023 subject to Rule 16b-3
 
Mellion Michelle L over six months ago
Disposition of 5901 shares by Mellion Michelle L of PepGen at 18.0049 subject to Rule 16b-3
 
Mellion Michelle L over six months ago
Disposition of 3288 shares by Mellion Michelle L of PepGen at 18.0448 subject to Rule 16b-3
 
Dable Habib J over six months ago
Acquisition by Dable Habib J of 13000 shares of PepGen at 16.8 subject to Rule 16b-3
 
Mellion Michelle L over six months ago
Disposition of 1086 shares by Mellion Michelle L of PepGen at 18.0614 subject to Rule 16b-3
 
Mellion Michelle L over six months ago
Disposition of 1411 shares by Mellion Michelle L of PepGen at 18.0 subject to Rule 16b-3
 
Niels Svenstrup over six months ago
Disposition of 10000 shares by Niels Svenstrup of PepGen at 13.41 subject to Rule 16b-3
 
Mellion Michelle L over six months ago
Acquisition by Mellion Michelle L of 83000 shares of PepGen at 16.62 subject to Rule 16b-3

PepGen Outstanding Bonds

PepGen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PepGen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PepGen bonds can be classified according to their maturity, which is the date when PepGen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

When determining whether PepGen is a strong investment it is important to analyze PepGen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PepGen's future performance. For an informed investment choice regarding PepGen Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PepGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
For more detail on how to invest in PepGen Stock please use our How to Invest in PepGen guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PepGen. If investors know PepGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PepGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of PepGen is measured differently than its book value, which is the value of PepGen that is recorded on the company's balance sheet. Investors also form their own opinion of PepGen's value that differs from its market value or its book value, called intrinsic value, which is PepGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PepGen's market value can be influenced by many factors that don't directly affect PepGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PepGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if PepGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PepGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.